Litigation Details for ASTRAZENECA PHARMACEUTICALS LP v. NATCO PHARMA LIMITED (D.N.J. 2023)
✉ Email this page to a colleague
ASTRAZENECA PHARMACEUTICALS LP v. NATCO PHARMA LIMITED (D.N.J. 2023)
Docket | ⤷ Sign Up | Date Filed | 2023-02-10 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Zahid Nisar Quraishi |
Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
Parties | MSD INTERNATIONAL BUSINESS GMBH | ||
Patents | 7,449,464; 8,475,842; 8,859,562 | ||
Attorneys | CHARLES H. CHEVALIER | ||
Firms | Midlige Richter LLC | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in ASTRAZENECA PHARMACEUTICALS LP v. NATCO PHARMA LIMITED
Details for ASTRAZENECA PHARMACEUTICALS LP v. NATCO PHARMA LIMITED (D.N.J. 2023)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2023-02-10 | 1 | Complaint | expiration of U.S. Patent No. 7,449,464 (“the ’464”); U.S. Patent No. 8,475,842 (“the ’842 patent”); and U.S.…U.S. Patent No. 8,859,562 (“the ’562 patent”). These patents are referred to collectively herein as the… the ’842 patent, including at least claims 1 and 7 of the ’842 patent, and the ’842 patent has been … 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C…United States Patent and Trademark Office (the “USPTO”) duly and lawfully issued the ’464 patent, entitled | External link to document |
2024-04-05 | 65 | Letter | issues relating to the validity of two patents, No. 7,449,464 and 8,859,562, that have been asserted …common in cases like this one involving claims of patent infringement brought under the Hatch-Waxman Act…bar, not just on use of the information, but on patent prosecution and competitive decision-making generally…10 February 2023 3:23-cv-00796 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |